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Purpose: To compare the acceptability of computed tomographic (CT) 
colonography and flexible sigmoidoscopy (FS) screening and 
the factors predicting CT colonographic screening participa-
tion, targeting participants in a randomized screening trial.
Materials and 
Methods:
Eligible individuals aged 58 years (n = 1984) living in Turin, 
Italy, were randomly assigned to be invited to screening for 
colorectal cancer with FS or CT colonography. After individ-
uals who had died or moved away (n = 28) were excluded, 
264 of 976 (27.0%) underwent screening with FS and 298 
of 980 (30.4%) underwent CT colonography. All attendees 
and a sample of CT colonography nonattendees (n = 299) 
were contacted for a telephone interview 3–6 months after 
invitation for screening, and screening experience and factors 
affecting participation were investigated. Odds ratios (ORs) 
were computed by means of multivariable logistic regression.
Results: For the telephone interviews, 239 of 264 (90.6%) FS at-
tendees, 237 of 298 (79.5%) CT colonography attendees, and 
182 of 299 (60.9%) CT colonography nonattendees respond-
ed. The percentage of attendees who would recommend the 
test to friends or relatives was 99.1% among FS and 93.3% 
among CT colonography attendees. Discomfort associated 
with bowel preparation was higher among CT colonography 
than FS attendees (OR, 2.77; 95% confidence interval [CI]: 
1.47, 5.24). CT colonography nonattendees were less likely 
to be men (OR, 0.36; 95% CI: 0.18, 0.71), retired (OR, 0.31; 
95% CI: 0.13, 0.75), to report regular physical activity (OR, 
0.37; 95% CI: 0.20, 0.70), or to have read the information 
leaflet (OR, 0.18; 95% CI: 0.08, 0.41). They were more likely 
to mention screening-related anxiety (mild: OR, 6.30; 95% 
CI: 2.48, 15.97; moderate or severe: OR, 3.63; 95% CI: 1.87, 
7.04), erroneous beliefs about screening (OR, 32.15; 95% 
CI: 6.26, 165.19), or having undergone a recent fecal occult 
blood test (OR, 13.69; 95% CI: 3.66, 51.29).
Conclusion: CT colonography and FS screening are well accepted, but 
further reducing the discomfort from bowel preparation 
may increase CT colonography screening acceptability. Neg-
ative attitudes, erroneous beliefs about screening, and or-
ganizational barriers are limiting screening uptake; all these 
factors are modifiable and therefore potentially susceptible 
to interventions.
q RSNA, 2017
Online supplemental material is available for this article.
Carlo Senore, MD, MSc
Loredana Correale, PhD
Daniele Regge, MD
Cesare Hassan, MD
Gabriella Iussich, MD
Marco Silvani, MD
Arrigo Arrigoni, MD
Lia Morra, PhD
Nereo Segnan, MD, MPH
Flexible sigmoidoscopy and cT 
colonography screening: Patients’ 
Experience with and Factors for 
Undergoing Screening—Insight from 
the Proteus Colon Trial1
This copy is for personal use only. To order printed copies, contact reprints@rsna.org
874 radiology.rsna.org n Radiology: Volume 286: Number 3—March 2018
GASTROINTESTINAL IMAGING: Flexible Sigmoidoscopy and CT Colonography Screening Senore et al
influencing participation in CT colonog-
raphy screening are still unknown.
In this article, we present the results 
of a survey comparing the acceptability 
of CT colonography versus FS screening 
and the factors that allow prediction of 
patient participation in CT colonograph-
ic screening, targeting participants in 
the Proteus colon trial (5,6).
Materials and Methods
This research was funded by the Pied-
mont Region Department of Health and 
Department of Technical Innovation and 
by im3D, Turin, Italy. L.C. and L.M. are 
employees of im3d. Authors who were 
not employees or consultants of im3D 
(C.H., C.S., N.S., D.R. and S.M.) had 
control of all data and information that 
might present a conflict of interest for 
the authors who were employees of or 
consultants for im3D. The local ethics 
review committees had approved the 
RCT protocol, including the survey of 
nonrespondents.
Study Population
Data were collected in the Proteus co-
lon trial, a randomized controlled trial 
in which the efficacy of CT colonography 
population-based screening program. 
In that trial, CT colonography showed 
equivalent diagnostic performance and 
participation to those of FS (6). To de-
sign effective screening programs, how-
ever, it is important to fully understand 
factors affecting acceptability of the 
test and the barriers to participation 
for subjects. Thus, screening experi-
ence and participation factors must be 
considered along with health outcomes.
To our knowledge, so far only one 
survey (7) in the Dutch screening trial 
(8) has included questions to assess pa-
tient satisfaction with and perception 
of CT colonography versus colonos-
copy. However, due to different study 
protocols and target populations, the 
generalizability of previous findings is 
uncertain. Furthermore, a direct com-
parison in the same population of the 
acceptability of CT colonography versus 
that of FS or the fecal immunochemical 
test, which are the screening strategies 
currently adopted by most population 
programs, is lacking.
Models of behavior change (9) pro-
pose that decisions to engage in health-
promoting behaviors are influenced by 
psychologic factors such as self-efficacy, 
perceived susceptibility to and perceived 
severity of the disease, and perceived 
barriers of the preventative health be-
havior. Research (10–14) has estab-
lished that many of these factors influ-
ence the decision to undergo screening 
for CRC. However, the specific factors 
https://doi.org/10.1148/radiol.2017170228
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Advances in Knowledge
 n In the context of a screening 
trial, most of the interviewees 
gave practical reasons (27.5%, 
work and family constraints or 
illness) and fear of embarrass-
ment (18.7%) for nonparticipa-
tion in CT colonography 
screening.
 n Erroneous beliefs about screening 
(odds ratio [OR], 32.1), high 
level of anxiety (OR, 3.6), sex-
related preferences (reference = 
male; OR, 2.8), lack of physical 
activity (OR, 2.8) are also bar-
riers to CT colonography 
screening.
 n Most frequently reported reasons 
for participation in the future 
were onset of symptoms (63% of 
interviewees) and having a pre-
consultation with the general 
practitioner (43%).
 n Although the experience of CT 
colonography screening was not 
problematic for the majority of 
participants, lower satisfaction 
scores were reported with CT 
colonography than with flexible 
sigmoidoscopy, due to a more 
burdensome bowel preparation 
(OR, 2.77; 95% CI: 1.47, 5.24).
 n The proportion of participants 
who would not recommend the 
test to friends or relatives, or 
who would not repeat the test in 
a future round, was low in both 
arms, although lower in flexible 
sigmoidoscopy arm (0.9% vs 
6.7% and 1.3% vs 7.2%).
Implications for Patient Care
 n Measures to improve participa-
tion in CT colonography 
screening must not only address 
organizational barriers, but also 
sex-specific barriers and people’s 
beliefs and attitudes toward 
screening, to help invitees to 
make informed decisions.
 n Among participants, bowel prep-
aration was identified as the 
most unpleasant aspect of the CT 
colonography screening proce-
dure; this result suggests the 
importance of further optimizing 
CT colonographic bowel prepara-
tion in a screening setting.
Once-only flexible sigmoidoscopy (FS), offered only once, when a patient is 55−60 years old, is cur-
rently recommended as one of the tests 
for colorectal cancer (CRC) screening 
(1–3). Computed tomographic (CT) 
colonography has been proposed as 
an alternative screening test (4). Re-
cently, the randomized controlled trial 
known as the Proteus colon trial (5,6) 
was performed to compare the par-
ticipation and detection rates with CT 
colonography with those of FS in a 
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to grade their intensity (none, mild, 
moderate, or severe). They were also 
requested to rate anxiety, embarrass-
ment, and pain associated with the ex-
amination on a five-point Likert scale (1 
= none, 5 = severe). The questionnaire 
was set according to factors in the Pre-
cede-Proceed model (9).
Predisposing factors included be-
liefs about screening benefits and effi-
cacy, attitude toward undergoing reg-
ular medical checkups (completely or 
moderately reassured or moderately or 
severely worried), perception of CRC 
risk, adoption of health-protective be-
haviors (eg, physical activity, no smok-
ing habits), and self-reported health 
status (good, fair, poor, or very poor), 
along with several sociodemographic 
factors including sex, age, education, 
and occupation. Enabling factors in-
cluded use of media (eg, newspapers, 
television, the Internet) and informa-
tion conveyed with the invitation (letter 
and information leaflet) and adoption of 
other preventive practices (Papanicolau 
test and mammography for women, 
prostate-specific antigen test for men). 
Reinforcing factors included seeking 
medical advice, knowing a close relative 
or friend with CRC, having undergone 
a previous test for early CRC detection. 
Nonattendees were also asked the main 
reason for declining screening, and they 
were then required to indicate whether 
a number of factors identified in previ-
ous studies (9,13) had influenced their 
decision making and what factors could 
induce them to accept future screening 
invitations.
Sample Size Calculation
Assuming a 25%–30% response rate 
in both arms, we expected 250–300 
attendees for both FS and CT colonog-
raphy. We planned to interview all of 
them and a 50% sample of CT colo-
nography nonattendees to achieve a 
one-to-one ratio of attendees to non-
attendees in this group. The planned 
size ensured 80% power (at a 5% level 
of significance) to detect absolute dif-
ferences greater than or equal to 8% 
in the prevalence of screening-related 
adverse effects in the comparison of 
CT colonography and FS attendees, 
were required to reach the radiology 
center 2 hours before the examination 
to receive the oral iodine solution (50 
mL) for fecal tagging. For colon insuf-
flation, carbon dioxide was used. The 
examinations were performed in three 
radiology units and were then trans-
ferred through a regional information 
and communication technology net-
work to a centralized reading center to 
be interpreted by a pool of experienced 
radiologists (Appendix E1 [online]).
Interview
For the purposes of this survey, two 
groups of subjects were targeted for a 
phone interview, all attendees in both 
CT colonography and FS arms (n = 
562) and all nonattendees (n = 399) in 
the CT colonography arm invited for 
screening in January 2013 (comprising 
50% of nonattendees, assuming a sim-
ilar participation rate throughout the 
two invitation periods). Subjects who 
phoned the screening center to de-
cline the invitation were excluded. In-
terviews were carried out 3–6 months 
after screening invitations were sent 
by trained interviewers who were not 
blinded to randomization arm, atten-
dance status, and screening results; 
therefore, interviewers could check the 
responses of subjects who had been re-
ferred for colonoscopy to be sure that 
they were reporting on the screening 
experience (Appendix E1 [online]).
Subjects who did not respond to 
five calls at different times and days (at 
least one call between 7 pm and 8 pm) 
were considered untraceable. When 
the subject was temporarily unavail-
able, the interviewer fixed an appoint-
ment for a second call: After three 
missed appointments, the subject was 
considered to have refused screening. 
Subjects who gave their consent to the 
telephone interview were administered 
a questionnaire regarding the subject’s 
experience with FS and CT colonogra-
phy, as well as factors influencing CT 
colonography attendance.
Content of the Interview Questionnaire
Attendees were asked to report adverse 
effects associated with both bowel 
preparation and test procedures and 
versus that of FS was studied in the 
context of a population-based screening 
program (5,6). The present analysis, 
aimed to measure patient satisfaction 
with the screening tests and determi-
nants of participation in CT colonog-
raphy screening, included all subjects 
who participated in screening with ei-
ther FS or CT colonography (n = 562) 
and those who did not respond to the 
invitation to undergo CT colonography 
(n = 399) in the second enrollment pe-
riod of the trial (January 2013).
The trial protocol has been de-
scribed in detail elsewhere (5). All indi-
viduals aged 58 years old living in Turin, 
Italy, were eligible for screening during 
the months of September 2012 and Jan-
uary 2013 and were randomly allocated 
(1:1) to be invited to undergo CT colo-
nography or FS screening (Appendix E1 
[online]). Eligible subjects (n = 1984) 
were mailed a personal letter, signed 
by their general practitioner, offering a 
prefixed test date. The letter included a 
leaflet describing the screening proce-
dure and its possible side effects. Sub-
jects were asked to call the screening 
center to confirm, modify, or cancel 
their appointment. A reminder letter 
was mailed to all subjects who did not 
respond to the initial invitation within 
45 days. Screening and related assess-
ments were offered free of charge to all 
subjects who attended the screening. 
All attendees gave written consent for 
the study procedures.
Bowel preparation for FS consist-
ed of a single enema (133 mL of 22% 
sodium phosphate) self-administered at 
home 2 hours before the test, without 
dietary restrictions. The examination 
was performed in the reference Endos-
copy Unit of the Turin screening pro-
gram by experienced endoscopists. In 
the FS arm, subjects were not required 
to reach the center before the sched-
uled time of their appointment. In the 
CT colonography arm, a reduced prepa-
ration procedure was self-administered 
(5,15), consisting of a low-residue diet 
for 3 days and a sachet of stool softener 
(diluted in one glass of water) at the 
three main meals starting 3 days before 
CT colonography. Unlike the FS partic-
ipants, CT colonography participants 
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and 15 of 264 (5.7%) could not be 
traced. Among the 298 CT colonogra-
phy attendees, 237 (79.5%) responded 
to the telephone interview, 34 of 298 
(11.4%) refused, and 27 of 298 (9.1%) 
could not be traced.
After excluding subjects who called 
the screening center to refuse screen-
ing (n = 14), those who reported under-
going a recent fecal occult blood test or 
conventional colonoscopy (n = 21) and 
those who met other exclusion criteria 
(n = 5), 299 CT colonography nonattend-
ees were eligible for the interview: 182 
(60.9%) responded, 16 (5.3%) refused, 
101 (33.8%) people were excluded be-
cause they could not be traced (n = 93) 
or were ill at the time of the interview (n 
= 8). There was not a bias in response 
according to sex for the survey of both 
FS attendees and CT colonography at-
tendees (P = .300) and CT colonogra-
phy nonattendees (P = .382) (Appendix 
E1 [online]). For the CT colonography 
nonattendees survey, the respondents 
group included a larger percentage of 
women than did the full target sample, 
which also included nonrespondents (P 
, .001) (Appendix E1 [online]). De-
mographic and clinical characteristics 
of the responders for each survey are 
described in Table 1.
of the tests could have been affected 
by survey timing. Predictors of screen-
ing participation were evaluated with 
univariate and multivariate logistic re-
gression analyses. We analyzed sepa-
rate models: the first was focused on 
factors associated with nonattendance 
among subjects invited for CT colonog-
raphy, and the second was focused on 
factors associated with participation in 
FS compared with that in CT colonog-
raphy screening among subjects. Odds 
ratios (ORs) and 95% confidence in-
tervals (CIs) were used as measures of 
association. Secondary analyses were 
performed to address the problem 
of differential recall bias among at-
tendees and nonattendees (Appendix 
E1 [online]). All statistical tests were 
two sided, and differences were con-
sidered statistically significant at a P 
value of .05.
Results
Of the 976 individuals invited to un-
dergo FS screening, 264 (27%) partic-
ipated, and of the 980 invited to un-
dergo CT colonography, 298 (30.4%) 
participated. Among FS attendees, 
238 of 264 (90.5%) responded to the 
interview, 10 of 264 (3.8%) refused, 
given their expected frequency 
(6,8,16,17), as well as absolute dif-
ferences of approximately 7%–15% in 
the distribution of putative predictors 
of participation in the comparison of 
CT colonography attendees and nonat-
tendees on the basis of their expected 
(6,10,14) distribution, ranging from 
9% (those with a positive family his-
tory) to 45% (the proportion of partic-
ipants who read the leaflet).
Data Analysis
Descriptive statistics were used to 
characterize the study population. 
Respondents, nonrespondents, and 
the full target sample were compared 
on the basis of sex. x2 statistics were 
used to test for statistically significant 
differences. Within each group of at-
tendees, we calculated the proportion 
of adverse effects (reported in the in-
terview) associated with the prepara-
tion or the test procedure. Identical 
items on perceived burden associated 
with the procedure were compared 
between CT colonography and FS 
attendees by using x2 statistics. Be-
cause interviews were performed 3–6 
months after the invitation, we also 
conducted a sensitivity analysis to as-
sess whether self-reported experience 
Table 1
Respondents’ Baseline Characteristics
Characteristic FS Attendees CT Colonography Attendees CT Colonography Nonattendees P Value* P Value† 
Invitees targeted for the interview 264 298 299 . . . . . .
No. of women invited 143 (54.2) 130 (44.8) 145 (48.5) . . . . . .
No. of respondents 239 (90.5) 237 (79.5) 182 (60.9) ,.001 ,.001
Sex .007 .002
 Female 132 (55.2) 101 (42.6) 105 (57.7)
 Male 107 (44.8) 136 (57.4) 77 (42.3)
Education‡ .0205 .154
 Primary school or intermediate degree 125 (53.2) 98 (42.2) 83 (49.7)
 High school or university 110 (46.8) 134 (57.8) 84 (50.3)
Family risk of CRC‡§ 28 (11.7) 25 (10.5) 7 (2.9) .773 .024
Prior endoscopy experience‡ 47 (19.8) 46 (19.8) 18 (10.0) ..999 .009
Note.—Unless otherwise indicated, data are number of subjects, with percentage in parentheses.
* Comparison of FS vs CT colonography attendees
† Comparison of CT colonography nonattendees vs CT colonography attendees
‡ Because not all respondents answered the questions on their family risk, education, and prior endoscopy experience, percentages for these items are not based on the total number of respondents, 
but on the total number of respondents who answered those questions.
§ First-degree relative with CRC.
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were three (1.3%) subjects, with three 
(100.0%) reporting moderate to severe 
discomfort. The reported symptoms 
occurred on the same day of the test 
in more than 90% of the patients and 
were generally self-limited, lasting no 
more than 6 hours in approximately 
67% of the patients. Only three sub-
jects (one in FS and two CT colonogra-
phy group) asked for their general prac-
titioner’s advice, while none reported 
having been admitted to the hospital or 
referred to an emergency department. 
The screening procedure (including the 
travel time to the screening center) was 
completed within 2 hours for 87.9% of 
subjects who underwent FS, while it 
required 3–4 hours for 79.2% of those 
who underwent CT colonography (who 
were required to drink the iodine solu-
tion for fecal tagging at the screening 
center 2 hours before the test).
Factors Predicting CT Colonography 
Participation
Tables 4 and 5 show results of logistic 
regression analyses. People who con-
sidered screening to be ineffective (OR, 
32.15; 95% CI: 6.26, 165.19), who 
entire screening procedure by 59 of 
237 (24.9%) and 86 of 237 (36.3%) 
CT colonography participants, respec-
tively, and by 42 of 239 (17.6%; OR, 
0.66; 95% CI: 0.41, 1.05) and 83 of 
239 (34.7%; OR, 0.95; 95% CI: 0.65, 
1.42) of FS participants, respectively.
The percentage of attendees who 
experienced postprocedure symp-
toms was 24.9% for CT colonography 
and 19.7% for FS (Table 3). A higher 
number of CT colonography attendees 
had multiple symptoms (25 attendees 
of CT colonography and 10 of FS; OR, 
2.69; 95% CI: 1.26, 5.83) and scored 
these symptoms as moderate to se-
vere (18 CT colonography and four FS; 
OR, 4.81; 95% CI: 1.60, 14.4). Bowel 
distension and abdominal pain, either 
alone or in combination, were the most 
common complaints in both groups, dis-
tension being more often rated as mod-
erate to severe in the CT colonography 
group (OR, 2.73; 95% CI: 1.24, 6.04). 
In this latter group, 22 (9.3%) subjects 
reported fecal incontinence after the 
test, and 16 (72.7%) subjects rated this 
discomfort as moderate to severe; the 
corresponding figures for the FS group 
Acceptability and Patient Experience with 
the Screening Tests
The percentage of attendees who would 
not recommend the test to friends or 
relatives (FS, 0.9%; CT colonography, 
6.7%; OR, 0.12; 95% CI: 0.13, 0.51) 
and who would not repeat the test in 
the future if invited (FS, 1.3%; CT 
colonography, 7.2%; OR, 0.16; 95% 
CI: 0.03, 5.8) was low in both arms, 
although it was significantly lower in the 
FS arm.
Table 2 shows the perceived em-
barrassment, pain, and burden of 
bowel preparation and screening pro-
cedures. Discomfort from the bowel 
preparation was more often rated as 
“moderate or severe” by those who 
underwent CT colonography (17.9%) 
than by those who underwent FS 
(7.3%; OR, 2.77; 95% CI: 1.47, 5.24), 
while self-reported moderate to severe 
pain (OR, 1.11; 95% CI: 0.68, 1.82), 
embarrassment (OR, 1.55; 95% CI: 
0.83, 2.95), and anxiety (OR, 1.31; 
95% CI: 0.62, 2.88) did not differ ac-
cording to arm. Bowel preparation and 
the examination itself were scored as 
the most burdensome aspects of the 
Table 2
Patients’ Experience with the Screening Test by Screening Modality and Sex
Patient Response
FS Screening CT Colonography Screening
Women Men Total Women Men Total 
Discomfort of bowel preparation* 130 103 233 99 136 235
 None 108 (83.1) 79 (76.7) 187 (80.3) 71 (71.7) 100 (73.5) 171 (72.8)
 Mild 12 (9.2) 17 (16.5) 29 (12.4) 5 (5.1) 17 (12.5) 22 (9.2)
 Moderate or severe 10 (7.7) 7 (6.8) 17 (7.3) 23 (23.2) 19 (14.0) 42 (17.9)
Embarrassment† 130 103 223 100 136 236
 1 111 (85.4) 82 (79.5) 193 (82.3) 69 (69.0) 105 (77.2) 174 (73.7)
 2 11 (8.5) 11 (10.6) 22 (9.4) 17 (17.0) 18 (13.2) 35 (14.8)
 .2 8 (6.2) 10 (9.7) 18 (7.7) 14 (14.0) 13 (9.6) 27 (11.4)
Anxiety† 130 103 233 100 137 236
 1 99 (76.2) 93 (90.3) 192 (82.4) 75 (75.0) 105 (76.1) 180 (76.0)
 2 19 (14.6) 9 (8.7) 28 (12.0) 14 (14.0) 26 (18.9) 40 (16.9)
 .2 12 (9.2) 1 (1.0) 13 (5.6) 11 (11.0) 6 (4.3) 17 (7.1)
Pain† 130 103 233 101 137 236
 1 84 (64.6) 83 (80.6) 167 (71.7) 62 (61.4) 91 (66.4) 152 (64.3)
 2 20 (15.4) 10 (9.7) 30 (12.9) 15 (15.0) 30 (21.9) 45 (18.9)
 .2 26 (20.0) 10 (9.7) 36 (15.4) 24 (24.0) 16 (11.7) 40 (16.8)
Note.—Data are number of patients who responded, with percentage in parentheses.
* Rated on a scale of 1–4 (1, none or tolerable; 2, mild; 3, moderate; 4, severe).
† Rated on a scale of 1–5 (1, none; 5, severe).
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who had their interviews at different 
intervals since the invitation. Also, 
no difference in the perceived bur-
den was observed among FS and CT 
colonography screenees interviewed 
at different time intervals since the 
examination (Appendix E1 [online]).
Discussion
We found that both FS and CT colonog-
raphy are well-tolerated screening tests. 
The most relevant difference is related 
to bowel preparation, which required 
longer time and was perceived as more 
burdensome in the CT colonography 
arm. Although the reduced preparation 
adopted in our study had been rated by 
patients as less unpleasant (5,15,18–21) 
and was associated with higher partic-
ipation in CT colonography screening 
(22) than that of full cathartic prepara-
tion, it is apparently still more burden-
some than the single self-administered 
enema required for FS. Bowel prepara-
tion was, however, also perceived as the 
most burdensome aspect of CT colonog-
raphy screening in trials (7,23) in which 
a noncathartic protocol was adopted. 
These results emphasize the importance 
of further optimizing CT colonography 
bowel preparation in a screening setting, 
where screenees’ satisfaction is an im-
portant feature of successful programs.
Abdominal pain and distension 
were the most important components 
of the self-reported postprocedural dis-
tress in both screening arms, distension 
nonattendees. Test-related risks or fear 
of the examination were mentioned 
by eight (4.4%) nonattendees. Onset 
of gastrointestinal symptoms, physi-
cian’s advice, the offer of an interview 
with a health professional (eg, nurse) 
or the offer of a noninvasive test men-
tioned, respectively, by 115 (63.2%), 
78 (42.9%), and 52 (28.6%) respon-
dents, were the most common reasons 
stated as potential triggers for accept-
ing screening in the future.
Compared with CT colonography 
attendees, FS attendees (Table 5) 
were less likely to be men (OR, 0.50; 
95% CI: 0.31, 0.80), to report high-
er levels of screening-related anxiety 
(moderate or severe vs no anxiety: 
OR, 0.44; 95% CI: 0.25, 0.77), and 
to mention having read the informa-
tion leaflet (OR, 0.16; 95% CI: 0.08, 
0.30), while they were more likely to 
report a higher educational level (OR, 
1.76; 95% CI: 1.13, 2.74), lower level 
of physical activity (OR, 0.65; 95% 
CI: 0.42, 1.00), and regular participa-
tion in other screening programs (OR, 
2.50; 95% CI: 1.06, 5.88). In addi-
tion, among attendees who were able 
to indicate a figure for the estimated 
CRC mortality reduction with screen-
ing, those who rated it high were 
more likely to belong in the FS than in 
the CT colonography attendees group 
(OR, 2.57; 95% CI: 1.46, 4.51). No 
difference in the reported trends for 
predictors of participation was ob-
served in the comparison of subjects 
reported higher levels of screening-
related anxiety (reference, no anxiety; 
mild: OR, 6.30; 95% CI: 2.48, 15.97; 
moderate or severe: OR, 3.63; 95% 
CI: 1.87, 7.04), who reported greater 
perceived CRC risk (. 15%; OR, 2.83; 
95% CI: 1.08, 7.41), and those who re-
ported a recent fecal occult blood test 
(OR, 13.69; 95% CI: 3.66, 51.29) were 
more likely to refuse a CT colonogra-
phy invitation. Men (OR, 0.36; 95% 
CI: 0.18, 0.71), subjects who read the 
mailed information (OR, 0.18; 95% CI: 
0.08, 0.41), those who were retired 
(OR, 0.31; 95% CI: 0.13, 0.75), those 
who reported regular physical activity 
(OR, 0.37; 95% CI: 0.20, 0.70), and 
those with friends or neighbors with 
CRC (OR, 0.15; 95% CI: 0.05, 0.49) 
were less likely to decline the invitation. 
There was not a statistically significant 
association between regular screening 
practice and CT colonography screen-
ing participation (OR, 1.24;[95% CI: 
0.46, 1.32). The observed associations 
between risk perception, screening be-
liefs, screening-related anxiety, and CT 
colonography participation remained 
significant even after attendees who 
had been referred for colonoscopy were 
excluded (Appendix E1 [online]).
The main reasons for refusing CT 
colonography screening were work 
or family constraints or current ill-
ness, mentioned by 50 (27.5%) of 
the 182 nonattendees; test-related 
embarrassment, by 34 (18.7%); and 
absence of symptoms, by 24 (13.2%) 
Table 3
Self-reported Symptoms after Examination 
Symptom
Symptoms (Any Score) Symptoms (Moderate or Severe)
FS (n = 239) CT Colonography (n = 237) OR* FS (n = 239) CT Colonography (n = 237) OR* 
Abdominal pain 30 (12.6) 33 (13.9) . . . 17 (7.1) 18 (7.6) . . .
Bowel distension 23 (9.6) 35 (14.8) . . . 9 (3.8) 23 (9.7) . . .
Anal irritation 1 (0.4) 6 (2.5) . . . 1 (0.4) 2 (0.8) . . .
Bleeding 0 (0) 1 (0.4) . . . 0 (0) 1 (0.4) . . .
Nausea or vomiting 0 (0) 7 (3.0) . . . 0 (0) 5 (2.1) . . .
Incontinence 3 (1.3) 22 (9.3) 8.05 (2.38, 27.28) 3 (1.3) 16 (6.8) . . .
At least one symptom 47 (19.7) 59 (24.9) . . . 26 (10.9) 37 (15.6) . . .
More than one symptom 10 (4.2) 25 (10.5) 2.69 (1.26, 5.83) 4 (1.8) 18 (7.6) 4.81 (1.60,14.40)
Note.—Unless otherwise indicated, data are number of patients, with percentage in parentheses.
* Data in parentheses are 95% CIs.
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Table 4
Comparison of CT Colonography Attendees versus Nonattendees and FS Attendees at Univariate Analysis
Characteristic
No. of CT Colonography  
Attendees
Nonattendees CT Colonography FS Attendees
No. of Nonattendees P Value* No. of Attendees P Value*
Sex .002 .006
 Female 101 (42.6) 105 (57.7) 132 (55.2)
 Male 136 (57.4) 77 (42.3) 107 (44.8)
Education .516 .020
 Primary school or intermediate degree 124 (53.0) 83 (49.7) 98 (42.2)
 High school or university 110 (47.0) 84 (50.3) 134 (57.8)
Physical activity ,.001 .086
 No or occasional physical activity 119 (52.0) 128 (74.9) 139 (59.9)
 At least once a month 110 (48.0) 43 (25.1) 93 (40.1)
Employment status ,.001 .187
 Employed 86 (36.9) 81 (49.4) 99 (43.2)
 Retired 67 (28.8) 20 (12.2) 50 (21.8)
 Unemployed 80 (34.3) 63 (38.4) 80 (34.9)
Attitude toward regular screening ,.001 .010
 No anxiety 152 (67.3) 50 (30.5) 184 (79.3)
 Mild anxiety 18 (8.0) 29 (17.7) 15 (6.5)
 Moderate or severe anxiety 56 (24.8) 85 (51.8) 33 (14.2)
Perceived risk of CRC .010 .007
 Risk unknown 126 (54.5) 97 (54.5) 110 (47.2)
 ,10% over 10 years 65 (28.1) 32 (18.0) 54 (23.2)
 .15% over 10 years 40 (17.3) 49 (27.5) 69 (29.6)
Expected CRC mortality reduction with screening .183 ,.001
 Did not know† 132 (56.4) 112 (62.9) 89 (38.2)
 High or very high 102 (43.6) 66 (37.1) 144 (61.8)
Reading information material ,.001 ,.001
 Did not read leaflet 21 (9.1) 63 (35.4) 70 (30.0)
 Read leaflet 211 (90.9) 115 (64.6) 163 (70.0)
Known relatives, friends, or neighbors with CRC ,.001 .712
 None 160 (68.4) 154 (57.2) 150 (64.4)
 Relatives 18 (7.7) 29 (10.8) 49 (21.0)
 Friends or neighbors 56 (23.9) 86 (32.0) 34 (14.6)
General practitioner’s advice ,.001 .872
 Did not seek advice 174 (75.3) 162 (91.0) 177 (76.0)
 Asked for advice 57 (24.7) 16 (9.0) 56 (24.0)
Self-reported health status ,.152 .027
 Good 141 (60.0) 84 (49.4) 133 (57.3)
 Fair 77 (32.8) 74 (43.5) 94 (40.5)
 Poor or very poor 17 (7.2) 12 (7.1) 5 (2.2)
Reads newspapers .141 .751
 Daily 67 (28.8) 61 (35.7) 64 (27.5)
 Two or three times a week 98 (42.1) 56 (32.7) 106 (45.5)
 Never or occasionally 68 (29.2) 54 (31.6) 63 (27.0)
Opinion about screening effectiveness ,.001 .156
 Allows for detection of early stage curable disease 231 (99.1) 126 (71.2) 233 (100.0)
 Not useful or useful only when symptoms are present 2 (0.9) 51 (28.8) 0 (0.0)
Self-reported practice of preventive tests for other cancer sites .051 .002
 None 201 (85.9) 135 (78.5) 220 (94.4)
 Mammography and Papanicolau test or prostate-specific  
 antigen test
33 (14.1) 37 (21.5) 13 (5.6)
Table 4 (continues)
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being perceived as more burdensome 
in the CT colonography arm. Although 
carbon dioxide was used for obtain-
ing pneumocolon for CT colonogra-
phy examination and air was used for 
distention during FS, the documented 
positive effect (24) of carbon dioxide in 
reducing patient discomfort was likely 
offset by the much larger gas volume 
needed to explore the entire colon with 
CT colonography. The proportion of CT 
colonography attendees reporting post-
procedural abdominal complaints was 
lower in our cohort than in the Dutch 
trial (7), which might be explained by 
the lower iodine dose in our protocol.
The positive correlation between 
CT colonography screening and male 
sex reflects the higher participation 
of men in CT colonography than in 
FS screening in the Proteus Colon 
randomized controlled trial (6). Our 
findings are also suggestive of a social 
gradient, because CT colonography 
attendees were more likely to have a 
lower education level than were FS at-
tendees. Findings concerning adoption 
of health-protective behaviors were not 
consistent. Previous practice of other 
screening tests was not associated 
with participation in CT colonography 
screening, while FS attendees were 
more likely to report having undergone 
the Papanicolau test, mammography, or 
prostate-specific antigen test. CT colo-
nography attendees were more likely 
Characteristic
No. of CT Colonography  
Attendees
Nonattendees CT Colonography FS Attendees
No. of Nonattendees P Value* No. of Attendees P Value*
Recent CRC screening tests ,.001 .484
 None 185 (78.7) 128 (71.9) 192 (82.4)
 Recent fecal occult blood test within past 2 years 4 (1.7) 32 (18.0) 5 (2.1)
 Colonoscopy or FS within past 5 years 46 (19.6) 18 (10.1) 36 (15.5)
Smoking habits .183 .512
 Never smoker 146 (62.7) 117 (70.5) 156 (67.5)
 Former smoker 50 (21.5) 32 (19.3) 41 (17.7)
 Smoker 37 (15.9) 17 (10.2) 34 (14.7)
Note.—Unless otherwise indicated, data are number of patients, with percentage in parentheses.
* Reference was CT colonography attendees.
† Among CT colonography attendees, three described the reduction in mortality with screening as low and 29 did not know the reduction in mortality; among CT colonography nonattendees, 10 
described it as low and 102 did not know; and among FS attendees, three described it as low and 86 did not know.
Table 4 (continued)
Comparison of CT Colonography Attendees versus Nonattendees and FS Attendees at Univariate Analysis
to report a regular practice of physical 
activity compared with nonattendees, 
which was consistent with findings from 
studies in which other CRC screening 
strategies were evaluated (25–27), but 
they were also more active than FS 
attendees. Thus the offer of CT colo-
nography screening may reach subjects 
showing a positive attitude toward 
health protective behaviors who are not 
yet familiar with preventive tests.
Less than 50% of CT colonography 
nonattendees and attendees in both 
screening arms were able to quan-
tify the expected mortality reduction 
with screening, with CT colonography 
attendees being more likely than FS 
attendees to mention a realistic esti-
mate of their 10-year CRC risk. Also, 
although results of previous reports 
(10,26,27) suggested that individuals 
who perceive themselves to be at higher 
risk for CRC are more likely to attend, 
a significantly higher proportion of CT 
colonography nonattendees overesti-
mated their personal CRC risk in our 
study. A possible explanation of these 
findings is that perceived susceptibility 
does not influence participation in CT 
colonography screening, but it is impor-
tant to orienting the decision of people 
invited for more invasive tests such as 
FS or colonoscopy, as has already been 
reported (10).
FS attendees were less likely to re-
port high levels of anxiety associated 
with regular repetition of screening 
tests compared with CT colonography 
attendees, while among CT colonogra-
phy invitees, even mild levels of anxiety 
were associated with a reduced likeli-
hood of participation. Subjects who are 
less confident in the protective effect 
of screening may prefer a less invasive 
test, while lower level of confidence 
and an overestimate of personal CRC 
risk may result in higher anxiety and 
in fatalistic beliefs about cancer, which 
represent a strong barrier to partic-
ipation. Only 4% of CT colonography 
nonattendees mentioned fear of the ex-
amination or related risks (including ra-
diation exposure) as barriers to atten-
dance, while fear of test-related pain, 
discomfort, or injury had been report-
ed previously as a major barrier to FS 
screening (10). This suggests that CT 
colonography may be perceived as less 
painful and invasive than FS. Concerns 
about embarrassment during the exam-
ination, mentioned by 20% of nonpar-
ticipants as a major barrier, may limit 
CT colonography screening uptake.
Screening was perceived as useful 
only when symptoms were present by 
29% of CT colonography nonattend-
ees, with most indicating the onset of 
symptoms as the main reason for fu-
ture participation in CRC screening. Al-
most all participants in both screening 
arms were instead well convinced of 
the importance of early CRC detection 
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Table 5
Multivariate Logistic Regression Model Comparing CT Colonography Attendees versus CT Colonography Nonattendees and FS 
Attendees
Variable
CT Colonography Nonattendees FS Attendees
No. of Subjects* OR No. of Subjects† OR 
Sex
 Female 173 1 214 1
 Male 188 0.36 (0.18, 0.71) 220 0.50 (0.31, 0.80)
Education
 Primary school or intermediate degree 189 1 209 1
 High school or university 172 1.27 (0.70, 2.31) 225 1.76 (1.13, 2.74)
Employment status
 Employed 149 1 173 1
 Retired 130 0.31 (0.13, 0.75) 150 0.76 (0.45, 1.27)
 Unemployed 82 0.55 (0.28, 1.08) 111 0.78 (0.45, 1.35)
Attitude toward screening
 No anxiety 186 1 318 1
 Mild anxiety 45 6.30 (2.48, 15.97) 32 0.76 (0.34, 1.73)
 Moderate or severe anxiety 130 3.63 (1.87, 7.04) 84 0.44 (0.25, 0.77)
Physical activity
 No or occasional physical activity 218 1 242 1
 At least once a month 143 0.37 (0.20, 0.70)* 192 (0.42, 1.00)
Reading information material
 Did not read leaflet 69 1 82 1
 Read leaflet 292 0.18 (0.08, 0.41) 352 0.16 (0.08, 0.30)
Perceived CRC risk
 Risk unknown 191 1 218 1
 ,10% over 10 years 88 1.15 (0.47, 2.80) 114 0.50 (0.26, 0.93)
 .15% over 10 years 82 2.83 (1.08, 7.41) 102 0.99 (0.51, 1.90)
Self-reported practice of other screening tests
 None 58 1 43 1
 Mammography and Papanicolau test or prostate-specific antigen test 303 1.24 (0.46, 1.32) 391 2.50 (1.06, 0.5.88)
Expected mortality reduction with CRC screening
 Unknown 207 1 201 1
 High or very high 164 0.86 (0.38, 1.98) 233 2.57 (1.46, 4.51)
General practitioner’s advice
 Did not seek advice 295 1 . . . . . .
 Asked for advice 66 0.52 (0.23, 1.17) . . . . . .
Opinion about screening effectiveness
 Screening allows detection of early stage curable disease 320 1 . . . . . .
 Not useful or useful only when symptoms are present 42 32.15 (6.26, 165.19) . . . . . .
CRC screening tests within the past years
 None 276 1 . . . . . .
 Recent fecal occult blood test 53 13.69 (3.66, 51.29) . . . . . .
 Colonoscopy or FS 32 0.86 (0.38, 1.91) . . . . . .
Known relatives, friends, or neighbors with CRC
 None 271 1 . . . . . .
 Relatives 51 0.73 (0.33, 1.65) . . . . . .
 Friends or neighbors 39 0.15 (0.05, 0.49) . . . . . .
Note.—In the first model, an OR greater than 1 suggests that the likelihood of not attending to CT colonography screening is higher among subjects who present with a certain characteristic compared 
with those who do not show that characteristic; in the second model, an OR greater than 1 suggests that attendees with a certain characteristic would have a higher likelihood to undergo screening 
with FS compared with CT colonography than those without that characteristic. Data in parentheses are 95% CIs.
* Number of subjects included in the model in each category (CT colonography attendees plus CT colonography nonattendees).
† Number of subjects included in the model in each category (CT colonography attendees plus FS attendees).
‡ P = .049.
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the same in the trial as it was in the 
regional screening program (3,17), and 
CT colonography uptake was compara-
ble with those in other studies (7,22), 
which would suggest that responders 
are representative of the attendees in 
our program. Only subjects aged 58 
who were eligible for inclusion in an es-
tablished FS program were enrolled in 
this study, and therefore, our findings 
may not extend to screening programs 
targeting a wider age range.
In spite of these limitations, our 
findings complement and extend those 
from previous work (7,14) and provide 
additional useful information to identify 
factors that influence patients’ experi-
ence and preferences for different tests 
and to develop targeted interventions. 
In conclusion, CT colonography and FS 
screening are well accepted. Further re-
ducing the discomfort from bowel prep-
aration may increase CT colonography 
acceptability. Negative attitudes, errone-
ous beliefs about screening, and organi-
zational barriers limit screening uptake. 
All of these factors are modifiable, and 
therefore, susceptible to interventions.
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